Patients with Crohn’s and Ulcerative Colitis Show Promising Results in Entyvio Clinical Trials

Patients with Crohn’s and Ulcerative Colitis Show Promising Results in Entyvio Clinical Trials
Recently compiled safety data from all clinical trials on Entyvio (vedolizumab) for patients with inflammatory bowel disease (IBD) show the drug is associated with low rates of new serious infections, infusion-related reactions, and cancers. The review of Entyvio’s safety data, published in the journal Gut, is the most comprehensive analysis of six clinical trials. The study was performed by Jean-Frédéric

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *